Choice Housing Investments: Strong Returns in Multifamily Real Estate
Why Choice Housing Investments?
The most recent completed quarter, gross annualized Cash on Cash returns were at 12.5% and the Preferred Return was delivered to all investors
We continue to see opportunities for investment, yet are stable enough to be selective and not chase deals that have marginal returns
Despite the current crisis, multifamily real estate has been a safe harbor. For the past two months, despite COVID and the related crisis, collections and occupancy have remained strong, especially versus other real estate sectors.
Verdego Aero: Leading the Electrification of the $1.2T Aerospace Industry
Background on Company
The aerospace market is being disrupted by electrification, creating opportunities for new types of aircraft, improved economics, and lower emissions.
Erik Lindbergh and a team of experienced technology and business leaders founded VerdeGo Aero to enable the next generation of clean, quiet, flight.
VerdeGo Aero’s electric powertrains deliver significant competitive advantages for aircraft manufacturers focused on high performance and low operating costs.
Customers in multiple aerospace market segments are leveraging VerdeGo Aero’s technologies in their next-generation aircraft designs.
VerdeGo Aero is backed by strategic industry investors with more than 100 years of aviation experience, certification expertise, and supply chain capability.
What You Will Learn From This Webinar
The dramatic impact that CO2 reduction, noise restrictions, and COVID19 are having on the aerospace market; and how this is creating disruptive opportunities.
How to differentiate between the reality and hype as more than 200 companies (VerdeGo’s customers) compete to design next generation electric aircraft.
Competitive advantages that enable VerdeGo to efficiently and effectively create a $1B+ opportunity with significant upside potential for its investors.
EPS Holdings: Get Off The Grid – The Future of Power Generation
BACKGROUND ON COMPANY
EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly efficient, re-engineered, small sized turbine engines.
Two separate models of these turbines will generate PRIMARY POWER (not just back-up power) for use in the residential, commercial, industrial, and retail sectors.
One turbine will be powered by natural gas or any other liquid or gaseous fuel. The other engine will run on any form of solid waste biomass, including animal waste, grass, sugar cane waste, wood chips, wood pellets or algae.
These uniquely designed engines are built to achieve superior efficiency that results in significant cost savings and substantial emission reductions.
These turbines are powerful enough to run anything from a village in Africa to a shopping mall, hospital, or educational facility in North America.
These engines are portable, light weight and designed to fit on the back of a flat-bed truck or inside a standard shipping container.
EPS has been granted exclusive access to the patents and other intellectual property on the enabling technology for their turbines through a long-term royalty-free license arrangement, with their manufacturing partner, Brayton Energy.
Several prospective customers have signed Letters of Intent with EPS and are eager to purchase both models.
WHAT YOU WILL LEARN FROM THIS WEBINAR
A live briefing from EPS Holdings representatives including Michael Daly, President and CEO on how EPS will provide an alternative cost efficient and “greener” solution to the way some people and end-users view power generation in the future.
How the two EPS turbines can be used for multiple purposes in so many different sectors.
The Company has raised U.S $6 million to date and is now seeking an additional U.S. $18 million to complete development and commence commercialization.
Ecellix Battery Technologies: eCell™ is a breakthrough technology for the $100B Li-ion Battery Market
BACKGROUND ON COMPANY
EPS is a privately held, technology driven company that is focused on developing new power solutions through the manufacturing of highly efficient, re-engineered, small sized turbine engines.
Two separate models of these turbines will generate PRIMARY POWER (not just back-up power) for use in the residential, commercial, industrial, and retail sectors.
One turbine will be powered by natural gas or any other liquid or gaseous fuel. The other engine will run on any form of solid waste biomass, including animal waste, grass, sugar cane waste, wood chips, wood pellets or algae.
These uniquely designed engines are built to achieve superior efficiency that results in significant cost savings and substantial emission reductions.
These turbines are powerful enough to run anything from a village in Africa to a shopping mall, hospital, or educational facility in North America.
These engines are portable, light weight and designed to fit on the back of a flat-bed truck or inside a standard shipping container.
EPS has been granted exclusive access to the patents and other intellectual property on the enabling technology for their turbines through a long-term royalty-free license arrangement, with their manufacturing partner, Brayton Energy.
Several prospective customers have signed Letters of Intent with EPS and are eager to purchase both models.
WHAT YOU WILL LEARN FROM THIS WEBINAR
A live briefing from EPS Holdings representatives including Michael Daly, President and CEO on how EPS will provide an alternative cost efficient and “greener” solution to the way some people and end-users view power generation in the future.
How the two EPS turbines can be used for multiple purposes in so many different sectors.
The Company has raised U.S $6 million to date and is now seeking an additional U.S. $18 million to complete development and commence commercialization.
RMS: Addressing Diabetes, the Fastest Growing Disease in the World
BACKGROUND ON COMPANY
Revolutionary cell therapy targeting a cure for both Type 1 and Type 2 diabetes
Successful demonstration of curative properties in animal models, with a human clinical trial targeted for 2021
Utilization of ethically derived human induced pluripotent stem cells (iPSC, non-embryonic), which have the potential for significant scaleup to reach greater patient populations while avoiding ethical concerns
RMS has been highly successful in obtaining significant non-dilutive capital from sources such as the NIH in order to supplement existing family office investors including Ratan Tata
RMS’ patented stem cell technology is built on over 20 years of research and unique scientific expertise
COVID-19 has demonstrated that diabetics are at significant risk for serious complications and death with the coronavirus, highlighting that diabetes puts significant parts of the population at risk
WHAT YOU WILL LEARN FROM THIS WEBINAR
Diabetes affects an estimated 463 million people worldwide and will rise to 700 million by 2040 without intervention, thus illustrating the urgent need for a therapeutic solution from RMS
Diabetes and its complications are costing the world healthcare system an estimated $825 billion annually
Learn how RMS’ technology can significantly reduce the great financial burden globally
Every 6 seconds a person dies from diabetes and continues to be one of the world’s fastest growing diseases
RMS’ therapeutic grade cells are directly analogous to the successful cadaveric islets procedure (insulin independence), but without the supply limitations, variability, high cost and inconsistencies of cadaver islets
Investments in companies that treat/monitor diabetes have produced extraordinary results…imagine the potential investment returns of a company that can cure diabetes
AgVest Advisors was started in 2018 by Chris Brawner to help institutions and individuals invest directly in US farmland. Chris has successfully invested ~$30M per year for current investors. Farmland is predominately a private market – Over 60% of AgVest investments are made through private deals using vast network of farmers and source points. AgVest Advisors provides full-service turnkey sourcing and on-going management services for direct farmland investments.
Chris will work with investors to create thesis and source farmland deals with his extensive network. He negotiates on behalf of the buyer with seller, provides diligence post contract and manages assets post purchase.
AgVest: Farmland Investing Provides Reliable Returns In Uncertain Times
Chris Brawner has been involved in over $650M in farmland investments over the past decade. Discover the benefits of investing in farmland during this webinar. By 2030 the global population is expected to be +8 Billion. The developing world’s middle class continues to update its diet which includes more protein, which will take more grains to provide. The world’s farmland acres are finite and continue to decrease due to industrialization and urbanization. In times of market volatility investors will look for asset classes that are consistent throughout economic cycle. Farmland has negative correlation with equities. Farmland has low volatility. Farmland has proven to have consistent returns in times of market volatility, provides consistent income and capital appreciation. USDA reports that over the past 50 years farmland has appreciated approximately 6.1% per anum.
AgVest Advisors was started in 2018 by Chris Brawner to help institutions and individuals invest directly in US farmland. Chris has successfully invested ~$30M per year for current investors. Farmland is predominately a private market – Over 60% of AgVest investments are made through private deals using vast network of farmers and source points. AgVest Advisors provides full-service turnkey sourcing and on-going management services for direct farmland investments.
Chris will work with investors to create thesis and source farmland deals with his extensive network. He negotiates on behalf of the buyer with seller, provides diligence post contract and manages assets post purchase.
Chromatix: The Biggest Thing To Happen To Color Since Pantone
Chromatix is an early stage company with proven patent portfolio of unique color changing chemistry that allows “color on demand” to provide a platform for multiple uses across diverse industries.
On demand color aesthetics for global brands
On demand light control for visual acuity
Established sales portfolio with multiple diverse use cases
Currently raising $10MM to consolidate sales, streamline supply chain and increase color portfolio.
WHAT YOU WILL LEARN FROM THIS WEBINAR
The unique color changing capabilities developed by the acknowledged world leader In electrochromic polymer technology.
How color on demand can drive recurring revenue from web services and build value in Information sales.
The diverse use cases that make this a revolution in manufacturing solutions
The opportunity for investment in a proven technology with proven management and a proven portfolio of customers
Nuzuna Zone Fitness: Where Technology Meets Fitness & Wellness With Positive Outcomes
Nuzuna Zone Fitness provides a revolutionary new power-driven training solution and functional workout system with a wireless EMS system built into a tracksuit. As a worldwide unique EMS functional workout system, it delivers the full potential for intense full-body muscle training with complete freedom of movement. The Nuzuna brand spans both deep and wide with the goal of reaching as many people as possible and delivering the highest quality product to them.
Experienced athletes, fitness trainers and personal trainers played a key role in Nuzuna’s development and it has been evaluated by orthopedic specialists, physiotherapists and medical technicians.
What you will learn from this webinar? The history of the EMS, Ways to improve your health & save your time – 20 minutes workout, Physical Therapy and product lines of Nuzuna – Skincare and Physical Therapy
Lactocore: Better Drugs for Depression and Anxiety
Lactocore is a preclinical stage company at the cutting edge of computer-aided drug discovery. There is a tremendous unmet need for new drugs with novel mechanisms of action and drastically improved safety profiles in the areas of depression and anxiety. Lactocore is focused on fast and efficient early stage development to generate high quality candidates suitable for partnering with bigger pharmaceutical companies. It is currently in the midst of a $10M round with $3M in to bring leading asset to the completion of preclinical and Phase I clinical studies, and to advance other candidates.
What you will learn from the webinar: Why novel drugs against depression and anxiety represent an attractive investment opportunity, and how Lactocore is uniquely positioned to capitalize on this new wave of interest to psychiatry indications.
Navigating The Pandemic Tax Implications Webinar Presented By Private Client Services Practice At BDO
Creative tax planning ideas that wealthy individuals and their families should consider amidst the myriad of market and governmental changes we’ve seen due to COVID-19 will be shared by BDO.
Discover how BDO clients are using net operating losses, excess business loss limitations, business succession strategies and other techniques to free up current cash flow and lock-in long term tax savings for years to come.
Private Client Services at BDO is a boutique practice within a global public accounting firm that offers a high touch approach to serving high net worth individuals, their families, family offices, C-Suite executives and other people with complicated tax and financial structures.